Its this Pharmacann that is going to distribute the products : https://www.pharmacann.com.au/ (a small private australian company)
Not this one https://www.pharmacann.com/ the one that you are referring to that was bought by medmen for $682 million of stock in 2018 (when medman shares were worth $7.50, they are now worth $0.23) so effectively pharmacann is worth $21 million of stock at todays price, so you are wrong even about the wrong company.
Seems EXL may be playing some games here, trying to trick investors into thinking deals are bigger than they are, using the same name as overseas companies. Clutching at straws here, lets see how much longer they are solvent.
